cimicoxib has been researched along with amitriptyline in 1 studies
*Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. [MeSH]
*Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. [MeSH]
| Studies (cimicoxib) | Trials (cimicoxib) | Recent Studies (post-2010) (cimicoxib) | Studies (amitriptyline) | Trials (amitriptyline) | Recent Studies (post-2010) (amitriptyline) |
|---|---|---|---|---|---|
| 16 | 7 | 13 | 6,935 | 1,381 | 1,060 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauchamp, G; Blair, J; de Lorimier, LP; Lussier, B; Monteiro, BP; Moreau, M; Pelletier, JP; Troncy, E | 1 |
1 trial(s) available for cimicoxib and amitriptyline
| Article | Year |
|---|---|
Pain characterization and response to palliative care in dogs with naturally-occurring appendicular osteosarcoma: An open label clinical trial.
Topics: Amitriptyline; Analgesics; Animals; Bone Neoplasms; Central Nervous System Sensitization; Dog Diseases; Dogs; Female; Gabapentin; Imidazoles; Male; Osteosarcoma; Pain; Pain Management; Pain Measurement; Pain Threshold; Palliative Care; Prospective Studies; Quality of Life; Sensory Thresholds; Sulfonamides | 2018 |